Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Leucine aminopeptidase measurement

Known as: LAP, Leucine Aminopeptidase, leucine aminopeptidase test 
The determination of the amount of leucine aminopeptidase related peptide present in a biological specimen.
National Institutes of Health

Related topics

Related topics

4 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium TerminologyLeucine Aminopeptidase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Plasma level of basic fibroblast growth factor increases with progression of chronic liver disease
Basic fibroblast growth factor (FGF) is thought to be involved in carcinogenesis and, to clarify its clinical significance, the… Expand
  • figure 1
2003
2003
Possible role of placental leucine aminopeptidase in the antiproliferative effect of oxytocin in human endometrial adenocarcinoma.
PURPOSE Oxytocin (OT) was reported to inhibit the proliferation of various neoplastic tissues and cells, however, the regulation… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Highly Cited
2002
Highly Cited
2002
Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats.
Chinese-herb nephropathy (CHN) is a rapidly progressive renal fibrosis associated with the intake of a Chinese herb (Aristolochia… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2002
2002
Differential distribution of placental leucine aminopeptidase/oxytocinase and aminopeptidase A in human trophoblasts of normal placenta and complete hydatidiform mole.
Placental leucine aminopeptidase (P-LAP)/oxytocinase (OTase) degrades several small peptides such as oxytocin (OT), arginine… Expand
2001
2001
Maternal serum placental leucine aminopeptidase (P‐LAP)/oxytocinase and preterm delivery
Objective: To test the applicability of maternal serum placental leucine aminopeptidase (P‐LAP) as a parameter for predicting… Expand
1984
1984
A domain-specific marker for the hepatocyte plasma membrane. III. Isolation of bile canalicular membrane by immunoadsorption
Previous immunolabeling studies (Roman, L.M., and A.L. Hubbard, 1983, J. Cell Biol., 96:1548-1558; Roman, L.M., and A.L. Hubbard… Expand
  • figure 1
  • figure 2
  • table I
  • table II
  • table III
1974
1974
Abnormal serum isoenzyme of leucine aminopeptidase (LAP) in malignant neoplastic disease
Leucine aminopeptidase (LAP) isoenzymes have been studied in the serum and urine of 53 consecutive patients with various types of… Expand
1960
1960
Localization of leucine aminopeptidase in serum and body fluids by starch gel electrophoresis.
Serum leucine aminopeptidase (LAP), as measured by the method of Goldbarg and Rutenburg (1), is elevated in patients with biliary… Expand
  • table I
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Highly Cited
1959
Highly Cited
1959
The measurement of activity of leucine aminopeptidase in serum, urine, bile, and tissues.
 
1959
1959
Serum leucine aminopeptidase activity in normal pregnancy and in patients with hydatidiform mole.
IN the course of investigating the rise in serum leucine aminopeptidase activity in pregnancy previously reported by Green et al… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE